Woman looking through a microscope in a laboratory

Manufacturing Expertise Bispecific / Multispecific Antibodies

Bispecific and multispecific antibodies introduce structural complexity, chain-pairing challenges, and enhanced analytical demands. Avid supports these advanced formats through optimized mammalian expression systems, robust purification strategies, and manufacturing controls designed to manage complexity at scale.

Overview

Advancing Bispecific & Multispecific
Antibody Programs

Key Bispecific Development & Manufacturing Considerations

  • Structural complexity and chain pairing
  • Aggregation control
  • Expression optimization
  • Formulation development
  • Advanced analytical characterization
  • Robust and scalable purification strategies

How Avid Supports Bispecific Programs

  • Platform-enabled development to accelerate complex programs
  • Process optimization for complex formats
  • Enhanced analytical characterization
  • Clinical and commercial manufacturing
  • Validated scale-up and lifecycle support
  • Formulation development

Learn More

Bispecific & Multispecific Antibody FAQs

Yes, when supported by optimized expression systems, robust process control and validated manufacturing infrastructure.

They require precise chain pairing and enhanced process controls to manage structural complexity and product consistency.

Connect with our team to discuss development timelines, manufacturing strategy, and scalable CGMP production.